« Previous Next »European Journal of Cancer
Volume 45, Issue 17 , Pages 3017-3026, November 2009

Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer

R.N. Whistance
- Department of Social Medicine, University of Bristol, Bristol, UK
- Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
- Department of General Surgery, North Bristol Trust, Bristol, UK
T. Conroy
- Department of Medical Oncology, Centre Alexis Vautrin, EA 4360, Nancy University, Vandoeuvre-les-Nancy, France
W. Chie
- School of Public Health and Graduate Institute of Preventive Medicine, National Taiwan University, Taiwan
A. Costantini
- Psycho-oncology Unit, Sant’Andrea Hospital, Sapienza University of Rome, Italy
O. Sezer
- Department of Oncology and Haematology, Charite´ – Universitätsmedizin Berlin, Germany
M. Koller
- Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany
C.D. Johnson
- University Surgical Unit, Southampton University Hospitals NHS Trust, Southampton, UK
S.A. Pilkington
- University Surgical Unit, Southampton University Hospitals NHS Trust, Southampton, UK
J. Arraras
- Department of Oncology, Hospital De Navarra, Pamplona, Spain
E. Ben-Josef
- Department of Radiation Oncology, University of Michigan, USA
A.M. Pullyblank
- Department of General Surgery, North Bristol Trust, Bristol, UK
P. Fayers
- Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
- Department of Cancer Research and Molecular Medicine, Norwegian University of Technology and Science, Trondheim, Norway
J.M. Blazeby
- Department of Social Medicine, University of Bristol, Bristol, UK
- Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
- Corresponding author: Address: Department of Social Medicine, Canynge Hall, University of Bristol, Bristol, UK. Tel.: +0117 928 3495; fax: +0117 925 2736.
on behalf of the European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Group